ICU Medical (ICUI) VP/GC Virginia Sanzone Sells 4,856 Shares

What Happened

• Virginia Ruth Sanzone, Vice President and General Counsel of ICU Medical (ICUI), sold a total of 4,856 shares in open-market transactions on September 3, 2026. The four trades were: 2,202 shares at $167.67 (≈ $369,203), 1,238 shares at $168.44 (≈ $208,523), 724 shares at $169.53 (≈ $122,736), and 692 shares at $171.51 (≈ $118,688). Total proceeds across the sales were approximately $819,150.
• These were sales (insider dispositions). Sales are common and can be for many personal or administrative reasons; they are not direct indications of company performance.

Key Details

• Transaction date: September 3, 2026 (all trades same day). Filing date/Period of Report: 2026-09-03 (timely filing).
• Reported prices are weighted averages for groups of multiple executions; reported per-trade price ranges: $167.20–$168.145; $168.21–$169.15; $169.50–$169.665; $170.775–$171.69 (see footnotes F2–F5).
• Total shares sold: 4,856. Total reported proceeds: ≈ $819,150.
• Shares owned after the transaction: not specified in the provided excerpt of the filing (check the full Form 4 for remaining beneficial ownership).
• Notable footnote: sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026 (F1). The filer offers to provide exact breakdowns of shares sold at individual prices upon request (F2–F5).

Context

• These were open-market sales made under a pre-established 10b5-1 plan, which generally allows insiders to sell at predetermined times and prices. There were no option exercises, awards, or gifts reported in this filing.
• For full details on remaining holdings or exact per-lot execution prices, consult the complete Form 4 filing or contact the company/SEC staff as noted in the footnotes.